Vigneshwar Ramakrishnan

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Human Serum Albumin (HSA) has been suggested to be an alternate biomarker to the existing Hemoglobin-A1c (HbA1c) marker for glycemic monitoring. Development and usage of HSA as an alternate biomarker requires the identification of glycation sites, or equivalently, glucose-binding pockets. In this work, we combine molecular dynamics simulations of HSA and(More)
  • 1